Serum and Salivary Sialic Acid and Nitric Oxide Levels Estimation and Comparison after Nonsurgical Periodontal Therapy in Generalised Chronic Periodontitis Patients

Introduction: An exigency for a biomarker arises to expeditiously detect the periodontal disease evolution and to advocate more robust therapy efficacy measurements. Nitric oxide and sialic acid have been proved to be potential inflammatory markers. Hence, the evaluation of the involvement of nitric oxide and sialic acid in periodontal disease will enable us to assimilate the aspect of the complex process of periodontal disease progression. Aim: To estimate and compare the effect of nonsurgical periodontal therapy on serum and salivary sialic acid and nitric oxide levels in generalised chronic periodontitis patients. Materials and Methods: This study was a case-control as well as an interventional study. The subjects for this study were recruited from the Meenakshi Ammal Dental College and Hospital, Chennai from April 2017 to October 2018. Hundred patients were selected for this study. Control group consisted of 50 periodontally healthy subjects and test group consisted of 50 generalised chronic periodontitis subjects. After blood and saliva sample collection for determination of salivary and serum sialic acid and nitric oxide levels, evaluation of periodontal parameters like plaque index, probing pocket depth and Clinical Attachment Level (CAL) was done. Then the test group subjects underwent nonsurgical periodontal therapy and on 90th day post SRP parameters were re-evaluated. The collected data were analysed with IBM SPSS Statistics software, Version 23.0. In the above statistical tool the probability value 0.05 was considered as significant level. Results: The mean difference of plaque index, probing pocket depth, CAL, serum sialic acid, salivary sialic acid, serum Nitric Oxide (NO) and salivary nitric oxide: between the control and test group at baseline was -2.05, -5.01 mm, -5.56 mm, -12.515 mg/dL, -11.97 mg/dL, -129.762 μMol/L and -78.978 μMol/L respectively; for the test group at baseline and 90 days after nonsurgical periodontal therapy was 1.332, 3.15 mm, 3.285 mm, 14.206 mg/dL, 12.76 mg/dL, 130.082 μMol/L, 82.004 μMol/L, respectively. All the values were statistically significant with p-value <0.001. Conclusion: Nonsurgical periodontal therapy led to a decrease in the serum and salivary sialic acid and nitric oxide levels in subjects with generalised chronic periodontitis. A decrease in biochemical parameters was associated with a reduction in probing pocket depth and gain in attachment level.

Serum sialic acid could be a diagnostic candidate of unstable angina and its expression in different numbers of lesion vessels in acute myocardial infarction: a retrospective study

Background: Acute coronary syndrome is one of the leading causes of morbidity and mortality worldwide. Intracoronary thrombosis caused by atherosclerotic unstable plaque rupture or erosion is considered as main pathological basis. There have no identified biomarkers about diagnosis of unstable angina and prognosis of acute myocardial infarction. Methods: A total of 509 consecutive patients admitted to the Affiliated Hospital of Qingdao University from February 2019 to December 2019 were successively recruited in this retrospective study and divided into three groups, unstable angina, acute myocardial infarction and death occurred within 24 hours of acute myocardial infarction in hospital and then to compare with a total of 87 healthy people (control group) during the same time from Regular Physical Examination Center of the Affiliated Hospital of Qingdao University. Mann-Whitney test, Kruskal-Wallis test, and Chisquared test were used to analyze different types of grouping. Univariate and multivariate regression analyses were performed to analyze the risk factors. Relative operating characteristic (ROC) curve analysis was also performed to determine the power of test. Results: our study suggested that serum sialic acid has a good diagnostic value in patients with unstable angina. Moreover, serum sialic acid is an independent risk factor of acute myocardial infarction. Serum sialic acid could be a candidate to distinguish Single/Double vascular lesions from Triple vascular lesions in acute myocardial infarction. Conclusions: serum sialic acid is a potential biomarker to distinguish unstable angina from normal and estimate the number of diseased vessels in patients with acute myocardial infarction.

ASSOCIATION OF SERUM SIALIC ACID AND SERUM URIC ACID LEVELS WITH FASTING BLOOD GLUCOSE LEVELS IN TYPE-2 DIABETES MELLITUS PATIENTS

Objectives: The objective of the study was to estimate the serum sialic acid and serum uric acid levels in patients with type-2 diabetes mellitus and non-diabetic individuals and determining the association of serum sialic acid and serum uric acid levels with fasting blood glucose levels in patients with type-2 diabetes mellitus and also in non-diabetic individuals. Methods: The study was a cross-sectional analysis where 70 individuals in the age group of 30–70 years participated during 6 months period. This included two groups, one for type-2 diabetes patients as cases and other non-diabetics as controls. In each group, 35 individuals participated. There were 15 males and 20 females in type-2 diabetic group and 16 males and 19 females in non-diabetic group. Fasting blood glucose, serum sialic acid, and serum uric acid were estimated in both the groups. Results: In this study, the serum sialic acid levels of type-2 diabetes mellitus were shown to be increased (76.60 ± 7.89) when compared to non-diabetics (39.66 ± 9.55) with a statistically significant, p < 0.001. The serum uric acid concentrations were also found to be slightly elevated in type-2 diabetes mellitus (4.48 ± 0.79) when compared to non-diabetics (4.28 ± 0.89) with a statistically non-significant, p = 0.323. Conclusion: Based on this study, it is concluded that serum sialic acid and serum uric acid levels have been found to be positively associated with type- 2 diabetes mellitus in both men and women, indicating the risk of developing microvascular complications in those patients. Therefore, estimating the sialic acid and uric acid levels can aid in the early diagnosis and prevention of microvascular complications caused by type-2 diabetes mellitus.

Acrylamide reduces plasma antioxidant vitamin levels in rats due to increased oxidative damage

ABSTRACT Objective Acrylamide is a potentially neurotoxic and carcinogenic chemical and naturally creates during the heating process of carbohydrate-rich foods, such as potato chips and breakfast cereals. Acrylamide might be ingested by people via consuming food that contains it. Therefore, we investigated the effect of acrylamidegiven orally to male and female rats on plasma retinoic acid and α-tocopherol and serum sialic acid and malondialdehyde levels. Method A total of 50 Wistar rats were used (25 female and 25 male, three-four weeks old). The rats of each sex were given 2 and 5mg/kg/day acrylamide via drinking water for 90 days. At the end of the treatment, the animals were euthanized by cervical dislocation. Blood specimens were collected through cardiac puncture, and serum and plasma samples were analysed using the high-performance liquid chromatography technique with a Ultraviolet detector. Results The analysis of the plasma and serum samples revealed that serum sialic acid and malondialdehyde levels in both sexes given 5mg/kg/day acrylamide were significantly increased, and the serum sialic acid levels were higher in female rats given 2mg/kg/day acrylamide. The plasma retinoic acid and α-tocopherol levels significantly decreased in both sexes given only the highest dose. Conclusion The results show that acrylamide causes an increase in oxidative stress and leads to a decrease in the levels of retinoic acid and α-tocopherol which play a role in the defense mechanism against this stress.